课题基金 / 基金详情

Multi-analyte Biosensor for Emerging Cardiac Markers

Multi-analyte Biosensor for Emerging Cardiac Markers
用于新兴心脏标志物的多分析物生物传感器
批准号:
6404111
负责人:
Charles D Pennington
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-12 至 2002-08-31

项目摘要

项目成果

Charles D Pennington的其他基金

相似基金

相关文献

中文摘要
翻译
露娜创新公司建议创建一种灵敏、高度特异的多分析物生物传感器,用于心脏标志物的量化。研究人员和医生都需要这个系统来改进对向急诊科报告胸痛的患者的评估和分诊。为快速量化包括心肌肌钙蛋白I、总肌酸激酶MB和肌红蛋白在内的常规标志物而设计的新的护理点诊断技术试图满足这一需求,但仅识别斑块破裂事件的下游影响。最近的研究表明,新出现的标志物,如P-选择素和D-二聚体,可能是斑块破裂或不稳定的早期指标。该系统利用露娜的长周期光栅光纤传感器和亲和膜技术,为传统和新兴心脏标志物的直接、实时测量创造了一个高度复用、灵活的平台。第一阶段的工作将展示带有肌酸激酶MB和P-选择素的传感器平台。在第二阶段计划期间,将识别更多的标记并将其整合到检测系统中。露娜之前已经展示了这项拟议的技术,用于快速、灵敏和特异地检测血清中的蛋白质p24。建议的系统将有助于研究多个心脏标志物的重要性,从而提高对心肌梗死的理解。建议的商业应用:建议的多分析物生物传感器系统立即应用于心肌梗死的研究和分类。测量多个心脏标志物的能力将提高研究人员和医生对导致斑块破裂和下游影响的机制的理解。一旦建立了该系统,就可以作为诊断点,如脓毒症的检测。其他医疗应用包括蛋白质组和药物开发市场的高通量筛选。第一阶段计划旨在演示传感器性能的正交确认,从而建立客户对这一新型传感技术的信心。
英文摘要
Luna Innovations proposes to create a sensitive, highly specific, multi- analyte biosensor for quantification of cardiac markers. This system is needed by both researchers and physicians to improve evaluation and triage of patients reporting to emergency departments with chest pain. New point-of-care diagnostic technologies designed for rapid quantification of conventional markers including, cardiac troponin I, total creatinase kinase MB, and myoglobin attempt to address this need, but only identify downstream effects of a plaque rupture event. Recent studies have suggested emerging markers, such as P-selectin and D- dimer, may be early indicators of plaque rupture or instability. The proposed system utilizes Luna's long period grating (LPG) optical fiber sensor and affinity film technology to create a highly multiplexed, flexible platform for direct, real-time measurement of conventional and emerging cardiac markers. Phase I work will demonstrate the sensor platform with creatine kinase MB and P-selectin. Additional markers will be identified and integrated into the detection system during the Phase II program. Luna has prreviously demonstrated the proposed technology for rapid, sensitive, and specific detection of a protein, p24, in serum. The proposed system will enable studies into the significance of multiple cardiac markers leading to an improved understanding of myocardial infarction. PROPOSED COMMERCIAL APPLICATIONS: The proposed multi-analyte biosensor system has immediate application in research and triage of myocardial infarction. The ability to measure multiple cardiac markers will improve researchers and physicians understanding of the mechanisms leading up to plaque rupture and downstream effects. Upon establishing the system as a point-of-care diagnostic areas, such as detection of sepsis. Additional medical applications include high throughput screening in proteomic and pharmaceutical development markets. The Phase I program has been designed to demonstrate orthogonal confirmation of sensor performance, thus building customer confidence in this novel sensing technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid, High Throughput Assay for Quantification of cAMP
  • 批准号:
    6337310
  • 项目类别:
  • 资助金额:
    $10.02万
  • 财政年份:
    2001
  • 负责人:
    Charles D Pennington
  • 依托单位:
海外基金